What Is Cyclotide? Definition and What Research Reports

Definition

A cyclotide is a small, plant-derived peptide of roughly 28 to 37 amino acid residues in which the N- and C-termini are joined into a continuous circular backbone, and in which six conserved cysteine residues form three disulfide bonds arranged so that one disulfide threads through a ring formed by the other two and their connecting backbone segments. This arrangement is called the cyclic cystine knot (CCK) motif, and it is the defining structural feature of the class. Cyclotides were first isolated from plants and have since been described across several plant families; a review of their chemistry summarised the CCK framework and the exceptional chemical, thermal and enzymatic stability that the motif confers (PMID 21526790). In the peptide literature the word is used both for the natural molecules themselves and, more loosely, for engineered analogues built on the same circular knotted framework.

This page is for educational purposes only and is not medical advice; consult a licensed physician about any medical question. Nothing here describes a protocol, and no cyclotide is presented as a therapy for human use.

What Class of Molecule It Is and Where It Comes From

Cyclotides sit within the broader group of disulfide-rich plant peptides. They are ribosomally synthesised — that is, encoded by genes and translated as precursor proteins — and then processed into the mature circular form. A review of cyclotide biosynthesis described how precursor proteins are processed and the backbone cyclised inside plant tissue, and discussed the enzymes implicated in that step (PMID 23809361). Because they are gene-encoded, cyclotide sequences can be varied by mutagenesis, which is one reason they attract interest as engineering templates.

Botanically, cyclotides have been reported in the Violaceae (violets), Rubiaceae (coffee family), Cucurbitaceae and other plant families. A 2004 study isolated and characterised cyclotides from Viola tricolor and reported cytotoxic activity for the isolated peptides in cell assays (PMID 14987049). A later overview framed cyclotides as disulfide-rich peptide toxins within plants, discussing their presumed defensive role (PMID 31682883).

Structural Subfamilies

Cyclotides are conventionally sorted into subfamilies based on backbone features. The chemistry review described the Möbius and bracelet subfamilies — distinguished by the presence or absence of a cis-proline–preceding residue that introduces a conceptual twist in the circular backbone — alongside the trypsin-inhibitor subfamily that shares the knot but differs in sequence (PMID 21526790).

How the Term Is Used in Peptide Research

In the research literature, "cyclotide" appears in three broad contexts. The first is natural product chemistry: isolating, sequencing and characterising new members from plant extracts. Analytical method development belongs here too — a 2023 report described an on-chip microfluidic approach to separating cyclotides, presented as an alternative to conventional chromatographic workflows (PMID 37720850).

The second is synthesis and production. Because cyclotides are circular and knotted, making them in the laboratory is non-trivial. A review covering both chemical synthesis and biosynthesis of the circular protein family described native chemical ligation strategies and the biosynthetic route as complementary ways of obtaining folded material (PMID 17002979). A methods chapter set out recombinant expression of cyclotides using expressed protein ligation in bacterial systems, describing how intracellular cyclisation and folding are achieved (PMID 32144675).

The third is scaffold engineering. Here the cyclotide framework is treated as a stable chassis onto which short bioactive sequences are grafted, with the knot intended to hold the graft in a defined conformation and resist degradation. A 2019 review discussed the potential of the cyclotide scaffold for drug development, covering grafting approaches and the stability properties that motivate them (PMID 31010257). Reported work in this area is preclinical.

What the Published Literature Reports

Reported biological activities for natural cyclotides span several assay categories, and in most cases researchers have linked the activity to interaction with lipid membranes rather than to a classical receptor.

Membrane and antimicrobial work

A 2017 study examined bactericidal activity of cyclotides and reported that selectivity for phosphatidylethanolamine-containing lipids determined which bacterial species were affected, tying the antimicrobial spectrum to membrane lipid composition (PMID 28669767). This membrane-targeting model recurs across the cyclotide literature as the proposed general mechanism.

Activity against invertebrates

Consistent with a plant-defence role, a 2023 study reported nematicidal activity for cyclotides, assessing toxicity against the nematode Caenorhabditis elegans (PMID 37099442). A broader overview positioned cyclotides as disulfide-rich peptide toxins in plants and discussed their toxicity profile in that context (PMID 31682883).

Cell-based cancer research

Cytotoxicity toward cultured cells has been reported since early isolation work: the study of cyclotides from Viola tricolor characterised the isolated peptides as cytotoxic in cell assays (PMID 14987049). More recently, a 2022 study reported that cyclotides chemosensitised glioblastoma cells to temozolomide in vitro (PMID 35044783). These are laboratory cell findings, not clinical outcomes.

Receptor-related signalling

Not all reported activity is membrane-lytic. A 2021 study reported that plant-derived cyclotides modulated κ-opioid receptor signalling in cell-based assays (PMID 34308635). The finding is notable because it describes a defined molecular target rather than generalised membrane disruption.

Toxicity and Adverse Findings: What Studies Report

The published cyclotide literature is preclinical, and "adverse effect" data in the usual clinical sense does not exist for this class. What researchers have documented instead is intrinsic cytotoxicity. The 2004 Viola tricolor work described the isolated cyclotides as cytotoxic in cell assays (PMID 14987049), and a 2019 overview characterised cyclotides as disulfide-rich peptide toxins within plants (PMID 31682883). Toxicity toward an invertebrate model was reported in a 2023 nematicidal study using C. elegans (PMID 37099442). The membrane-selectivity study reported that lipid composition governed which cells were affected, which is the mechanistic basis usually invoked when researchers discuss selectivity between target and non-target cells (PMID 28669767). No human dosing data appear in the verified literature summarised here, and none is described on this page.

Common Points of Confusion

• Cyclotide vs. cyclic peptide generally. All cyclotides are cyclic peptides, but most cyclic peptides are not cyclotides; the term requires the head-to-tail backbone plus the knotted three-disulfide core (PMID 21526790).
• Cyclotide vs. a drug. The scaffold is discussed in the literature as a starting point for drug development rather than as a finished agent (PMID 31010257).
• Natural vs. engineered. Grafted analogues share the framework but carry sequences not found in plants; the review of scaffold potential covers this design strategy (PMID 31010257).
• Synthesis route matters. Material can be plant-extracted, chemically synthesised (PMID 17002979) or recombinantly expressed (PMID 32144675), and the literature treats these as distinct workflows.

References

• The chemistry of cyclotides (The Journal of Organic Chemistry, 2011)
• Cyclotide biosynthesis (Current Opinion in Chemical Biology, 2013)
• Chemical synthesis and biosynthesis of the cyclotide family of circular proteins (IUBMB Life, 2006)
• Recombinant Expression of Cyclotides Using Expressed Protein Ligation (Methods in Molecular Biology, 2020)
• On chip microfluidic separation of cyclotides (Turkish Journal of Chemistry, 2023)
• The Potential of the Cyclotide Scaffold for Drug Development (Biomedicines, 2019)
• Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra (BBA Biomembranes, 2017)
• Nematicidal Activity of Cyclotides: Toxicity Against Caenorhabditis elegans (Journal of Natural Products, 2023)
• Cyclotides: Disulfide-rich peptide toxins in plants (Toxicon, 2019)
• Cytotoxic cyclotides from Viola tricolor (Journal of Natural Products, 2004)
• Cyclotides Chemosensitize Glioblastoma Cells to Temozolomide (Journal of Natural Products, 2022)
• Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling (Journal of Natural Products, 2021)